Effectiveness and Safety of Convalescent Plasma Therapy on COVID-19 Patients With Acute Respiratory Distress Syndrome

Clinical Trial ID NCT04380935

Rank	Title	Journal	Year	PubWeight™‹?›
1	Acute respiratory distress syndrome: the Berlin Definition.	JAMA	2012	21.04
2	Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.	Lancet	2020	18.32
3	Clinical Characteristics of Coronavirus Disease 2019 in China.	N Engl J Med	2020	9.53
4	Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea.	N Engl J Med	2016	6.22
5	The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis.	J Infect Dis	2014	1.88
6	Hospital Incidence and Outcomes of the Acute Respiratory Distress Syndrome Using the Kigali Modification of the Berlin Definition.	Am J Respir Crit Care Med	2016	1.56
7	Pathological findings of COVID-19 associated with acute respiratory distress syndrome.	Lancet Respir Med	2020	1.38
8	Use of convalescent plasma therapy in SARS patients in Hong Kong.	Eur J Clin Microbiol Infect Dis	2005	1.23